ACADIA PharmaceuticalsCompany Review & Valuation
ACAD
Nasdaq
About ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associ… Show more ated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Show less
Industry
Biotechnology
HQ Location
San Diego, California
Website
Wikipedia
Stock Price
Price data not available for ACADIA Pharmaceuticals.
Performance
Please login or create a free account to view the contents of this section.
Valuation
Please login or create a free account to view the contents of this section.